Search Results - "CHISHOLM, Jeffrey W"

Refine Results
  1. 1

    Inhibition of stearoylCoA desaturase activity blocks cell cycle progression and induces programmed cell death in lung cancer cells by Hess, Daniel, Chisholm, Jeffrey W, Igal, R Ariel

    Published in PloS one (30-06-2010)
    “…Lung cancer is the most frequent form of cancer. The survival rate for patients with metastatic lung cancer is approximately 5%, hence alternative therapeutic…”
    Get full text
    Journal Article
  2. 2

    Inhibition of stearoylCoA desaturase-1 inactivates acetyl-CoA carboxylase and impairs proliferation in cancer cells: role of AMPK by Scaglia, Natalia, Chisholm, Jeffrey W, Igal, R Ariel

    Published in PloS one (27-08-2009)
    “…Cancer cells activate the biosynthesis of saturated fatty acids (SFA) and monounsaturated fatty acids (MUFA) in order to sustain an increasing demand for…”
    Get full text
    Journal Article
  3. 3

    Stearoyl-CoA desaturase activity modulates the activation of epidermal growth factor receptor in human lung cancer cells by Nashed, Mary, Chisholm, Jeffrey W, Igal, R Ariel

    “…Stearoyl-CoA desaturase-1 (SCD1), the main enzyme that converts saturated fatty acids into monounsaturated fatty acids, is a key factor in the mechanisms of…”
    Get more information
    Journal Article
  4. 4

    The LXR ligand T0901317 induces severe lipogenesis in the db/db diabetic mouse by Chisholm, Jeffrey W., Hong, Jenny, Mills, Scott A., Lawn, Richard M.

    Published in Journal of lipid research (01-11-2003)
    “…Liver X receptor (LXR) ligands are currently being evaluated as potential therapeutic agents for the treatment of low HDL. The LXR ligand T0901317 elevates ATP…”
    Get full text
    Journal Article
  5. 5

    ApoA-I secretion from HepG2 cells: evidence for the secretion of both lipid-poor apoA-I and intracellularly assembled nascent HDL by Chisholm, Jeffrey W, Burleson, Ellen R, Shelness, Gregory S, Parks, John S

    Published in Journal of lipid research (01-01-2002)
    “…The goal of this study was to determine whether apolipoprotein A-I (apoA-I) is lipidated before secretion by HepG2 cells. ApoA-I was extracted from microsomes…”
    Get full text
    Journal Article
  6. 6

    HDLs in apoA-I transgenic Abca1 knockout mice are remodeled normally in plasma but are hypercatabolized by the kidney by Lee, Ji-Young, Timmins, Jenelle M, Mulya, Anny, Smith, Thomas L, Zhu, Yiwen, Rubin, Edward M, Chisholm, Jeffrey W, Colvin, Perry L, Parks, John S

    Published in Journal of lipid research (01-10-2005)
    “…Patients homozygous for Tangier disease have a near absence of plasma HDL as a result of mutations in ABCA1 and hypercatabolize normal HDL particles. To…”
    Get full text
    Journal Article
  7. 7

    Effect of Ranolazine on A1C and Glucose Levels in Hyperglycemic Patients With Non-ST Elevation Acute Coronary Syndrome by Chisholm, Jeffrey W, Goldfine, Allison B, Dhalla, Arvinder K, Braunwald, Eugene, Morrow, David A, Karwatowska-Prokopczuk, Ewa, Belardinelli, Luiz

    Published in Diabetes care (01-06-2010)
    “…OBJECTIVE: We determined the relationships between glycemia at randomization, concurrent antidiabetic therapy, and change in A1C and fasting plasma glucose…”
    Get full text
    Journal Article
  8. 8

    Negative Charge at Amino Acid 149 Is the Molecular Determinant for Substrate Specificity of Lecithin:Cholesterol Acyltransferase for Phosphatidylcholine Containing 20-Carbon sn-2 Fatty Acyl Chains by Zhao, Yue, Wang, Jingchuan, Gebre, Abraham K., Chisholm, Jeffrey W., Parks, John S.

    Published in Biochemistry (Easton) (02-12-2003)
    “…We previously described a point mutation in human LCAT (E to A at residue 149; hE149A) that demonstrated greater activity with phosphatidylcholine (PC)…”
    Get full text
    Journal Article
  9. 9

    A1 adenosine receptor: role in diabetes and obesity by Dhalla, Arvinder K, Chisholm, Jeffrey W, Reaven, Gerald M, Belardinelli, Luiz

    “…Adenosine mediates its diverse effects via four subtypes (A(1), A(2A), A(2B) and A(3)) of G-protein-coupled receptors. The A(1) adenosine receptor (A(1)AR)…”
    Get more information
    Journal Article
  10. 10

    Adenosine A1 receptors do not play a major role in the regulation of lipogenic gene expression in hepatocytes by Yang, Ming, Chu, Ruth, Chisholm, Jeffrey W., Doege, Holger, Belardinelli, Luiz, Dhalla, Arvinder K.

    Published in European journal of pharmacology (15-05-2012)
    “…Activation of adenosine A1 receptors was reported to promote fatty acid synthesis in AML-12 cells, by increasing the expression of SREBP-1c (sterol regulatory…”
    Get full text
    Journal Article
  11. 11

    Sulfonylureas uncouple glucose-dependence for GPR40-mediated enhancement of insulin secretion from INS-1E cells by Yang, Ming, Chisholm, Jeffrey W., Soelaiman, Sandriyana, Shryock, John C.

    Published in Molecular and cellular endocrinology (05-02-2010)
    “…Activation of GPR40 is reported to enhance insulin secretion in the presence of glucose. We determined whether sulfonylureas could replace glucose for…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Characterization of C-terminal histidine-tagged human recombinant lecithin:cholesterol acyltransferase by Chisholm, J W, Gebre, A K, Parks, J S

    Published in Journal of lipid research (01-08-1999)
    “…Lecithin:cholesterol acyltransferase (LCAT) is the plasma enzyme that catalyzes esterification of the sn-2 fatty acid of phospholipid to cholesterol. To…”
    Get full text
    Journal Article
  14. 14

    Liver X receptors alpha and beta regulate renin expression in vivo by Morello, Fulvio, de Boer, Rudolf A, Steffensen, Knut R, Gnecchi, Massimiliano, Chisholm, Jeffrey W, Boomsma, Frans, Anderson, Leonard M, Lawn, Richard M, Gustafsson, Jan-Ake, Lopez-Ilasaca, Marco, Pratt, Richard E, Dzau, Victor J

    Published in The Journal of clinical investigation (01-07-2005)
    “…The renin-angiotensin-aldosterone system controls blood pressure and salt-volume homeostasis. Renin, which is the first enzymatic step of the cascade, is…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Lipid-sensing high-throughput ApoA-I assays by Niedziela-Majka, Anita, Lad, Latesh, Chisholm, Jeffrey W, Lagpacan, Leanna, Schwartz, Karen, Hung, Magdeleine, Jin, Debi, Fung, Wanchi, Brendza, Katherine M, Liu, Xiaohong, Pagratis, Nikos, Sakowicz, Roman

    Published in Journal of biomolecular screening (01-09-2012)
    “…Apolipoprotein A-I (ApoA-I), a primary protein component of high-density lipoprotein (HDL), plays an important role in cholesterol metabolism mediating the…”
    Get more information
    Journal Article
  17. 17
  18. 18

    Human apoA-I expression in CETP transgenic rats leads to lower levels of apoC-I in HDL and to magnification of CETP-mediated lipoprotein changes by Masson, David, Pais de Barros, Jean-Paul, Zak, Zoulika, Gautier, Thomas, Le Guern, Naig, Assem, Mahfoud, Chisholm, Jeffrey W, Paterniti, Jr, James R, Lagrost, Laurent

    Published in Journal of lipid research (01-02-2006)
    “…Plasma cholesteryl ester transfer protein (CETP) has a profound effect on neutral lipid transfers between HDLs and apolipoprotein B (apoB)-containing…”
    Get full text
    Journal Article
  19. 19

    Accumulation of cholestatic lipoproteins in ANIT-treated human apolipoprotein A-I transgenic rats is diminished through dose-dependent apolipoprotein A-I activation of LCAT by Chisholm, Jeffrey W, Paterniti, James R, Dolphin, Peter J

    Published in Biochimica et biophysica acta (27-09-2000)
    “…Administration of α-naphthylisothiocyanate (ANIT) to rats induces changes to plasma lipids consistent with cholestasis. We have previously shown (J. Lipid Res…”
    Get full text
    Journal Article
  20. 20